GAITHERSBURG, Md., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has been awarded approximately $20 million to develop and manufacture an ...

San Diego, California — It's still early days, but brand-new formulations of rescue benzodiazepine could be in store for patients who have acute repetitive seizures (ARS). Promising phase 3 trial ...

Meridian Medical Technologies, Inc. has been manufacturing auto-injectors for emergency drug delivery for more than 50 years and has provided more than 185 million auto-injectors to the world market.

CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation platforms to develop and commercialize ready-to-use injectable ...

Emergent Biosolutions Inc., of Gaithersburg, Md., said it was awarded about $20 million to develop and manufacture an auto-injector containing diazepam (5 mg/mL) to treat nerve agent-induced seizures.

A St. Louis-area manufacturing plant, which has served as a key supplier of an antidote to sarin nerve gas for the military and civilian first responders, has suspended production due to ...

LONDON (CBS.MW) -- King Pharmaceuticals KG, said its evaluating how address concerns of the U.S. Food and Drug Administration as it intends to amend or resubmit its new drug application for ...

Hikma is offering a Diazepam injection in a 50 mg/10 ml dose. Diazepam injection is indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety as well as ...